Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.35 - $0.53 $6,313 - $9,560
18,039 Added 19.95%
108,455 $55,000
Q3 2023

Nov 14, 2023

SELL
$0.38 - $0.58 $8,653 - $13,207
-22,772 Reduced 20.12%
90,416 $35,000
Q2 2023

Aug 14, 2023

BUY
$0.39 - $0.94 $44,143 - $106,396
113,188 New
113,188 $50,000
Q4 2022

Feb 14, 2023

BUY
$1.41 - $2.5 $31,805 - $56,392
22,557 New
22,557 $35,000
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.98 $33,557 - $92,749
23,304 Added 87.1%
50,060 $87,000
Q1 2022

May 16, 2022

BUY
$2.97 - $5.2 $79,465 - $139,131
26,756 New
26,756 $96,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $106,969 - $172,215
-17,170 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.81 - $16.96 $151,267 - $291,203
17,170 New
17,170 $159,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.